Breast Cancer Incidence Trends and Projections in Northeastern Thailand

Virani, Shama; Chindaprasirt, Jarin; Wirasorn, Kosin; Sookprasert, Aumkhae; Somintara, Ongart; Vachirodom, Damnern; Koonmee, Supinda; Srinakarin, Jiraporn; Kamsa‐ard, Supot; Suwanrungruang, Krittika; Rozek, Laura S.; Sriplung, Hutcha; Wiangnon, Surapon

doi:10.2188/jea.je20170045

Cited by 15 publications

(14 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In China, it was estimated that there were 67,328 new breast cancer cases (16.3% of all cancer cases) and 16, 178 deaths (7.8% of all deaths) occurred in 2015 [2]. In addition, over the past decades, the prevalence of breast cancer is rising and getting younger gradually [3][4][5], which has caused serious economic burden and become an important global public health issue.…”

Section: Introductionmentioning

confidence: 99%

Body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies

Wang

Cai

et al. 2020

BMC Cancer

View full text Add to dashboard Cite

Background: Since body mass index (BMI) is a convincing risk factor for breast cancer, it is speculated to be associated with lymph node metastasis. However, epidemiological studies are inconclusive. Therefore, this study was conducted to investigate the effect of BMI on the lymph node metastasis risk of breast cancer. Methods: Cohort studies that evaluating BMI and lymph node metastasis in breast cancer were selected through various databases including PubMed, PubMed Central (PMC), Web of science, the China National Knowledge Infrastructure (CNKI), Chinese Scientific Journals (VIP) and Wanfang Data Knowledge Service Platform (WanFang) until November 30, 2019. The two-stage, random effect meta-analysis was performed to assess the dose-response relationship between BMI and lymph node metastasis risk. Between-study heterogeneity was assessed using I 2. Subgroup analysis was done to find possible sources of heterogeneity. Results: We included a total of 20 studies enrolling 52,904 participants. The summary relative risk (RR) (1.10, 95%CI: 1.06-1.15) suggested a significant effect of BMI on the lymph node metastasis risk of breast cancer. The doseresponse meta-analysis (RR = 1.01, 95%CI: 1.00-1.01) indicated a positive linear association between BMI and lymph node metastasis risk. For every 1 kg/m 2 increment of BMI, the risk of lymph node metastasis increased by 0.89%. In subgroup analyses, positive linear dose-response relationships between BMI and lymph node metastasis risk were observed among Asian, European, American, premenopausal, postmenopausal, study period less than 5 years, and more than 5 years groups. For every 1 kg/m 2 increment of BMI, the risk of lymph node metastasis increased by 0.99, 0.85, 0.61, 1.44, 1.45, 2.22, and 0.61%, respectively. Conclusion: BMI significantly increases the lymph node metastasis risk of breast cancer as linear dose-response reaction. Further studies are needed to identify this association.

show abstract

Section: Introductionmentioning

confidence: 99%

Body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies

Wang

Cai

et al. 2020

BMC Cancer

View full text Add to dashboard Cite

show abstract

“…In China, the age-standardized incidence of breast cancer was observed at 28.4 per 100,000 women (11). In Vietnam's neighboring country Thailand, the incidence rate was estimated to be 31.2 per 100,000 woman-years (12). In our study, the age-standardized incidence rate was 21.5 per 100,000 women over the period of 2011 and 2015, which can still be considered low relative to populations in more economically developed countries.…”

Section: Discussionmentioning

confidence: 99%

Trends in breast cancer incidence in Ho Chi Minh City 1996 - 2015: a registry-based study

Pham

Bui

et al. 2020

Preprint

View full text Add to dashboard Cite

Background and Aims: The burden of breast cancer in Vietnam has not been documented. This study sought to estimate the incidence of breast cancer in Ho Chi Minh City, the largest economic center of Vietnam, from 1996 to 2015.Methods: This was a population-based study using the Ho Chi Minh City Cancer Registry as a source of data (coverage period: 1996 - 2015). The Registry adopted the International Classification of Diseases for Oncology, 3rd Edition for the classification of primary sites and morphology, and guidelines from the International Agency for Research on Cancer and the International Association of Cancer Registries. Using the population statistics from census data of Ho Chi Minh City, the point incidence of breast cancer for each 5-year period was estimated. Based on the national population, we calculated the age-standardized rate (ASR) of breast cancer between 1996 and 2015.Results: Overall 14,222 new cases of breast cancer (13,498 women, or 95%) had been registered during the 1996-2015 period; among whom, just over half (52%) were in the 2nd stage, and 26% in the 3rd and and 4th stages. In women, the median age at diagnosis was 50 years and there was a slight increase over time. The age-standardized incidence rate of breast cancer during 2011-2015 period was 21.5 cases per 100,000 women, representing an increase of 70% compared to the rate in 1996-2000 period. In men, there was also a significant increase in the age-standardized incidence rate: from 0.22 during the 1996-2001 period to 0.46 per 100,000 men during the 2011-2015 period.Conclusions: These very first data from Vietnam suggest that although the incidence of breast cancer in Vietnam remains relatively low, it has increased over time, and that the increase was mainly attributable to those age groups of 50 and 70.

show abstract

“…Wearing bra is not associated with breast cancer risk [443] but wearing (tight) bras for many hours and having breast implants [442], [445] may have associations. Around 60% of breast cancer mortality occurs in LMICs [446]. Conflicting data exists about the influence of oral contraceptive pills (OCPs) on the development of breast cancer.…”

Section: C) Breast Cancermentioning

confidence: 99%

Clinical Pharmacists in Chronic Care

Mohiuddin¹

2019

GJMR

View full text Add to dashboard Cite

Pharmacy practice has changed significantly lately. The professionals have the chance to contribute straightforwardly to patient consideration so as to lessen morbimortality identified with medication use, promoting wellbeing and preventing diseases. Healthcare organizations worldwide are under substantial pressure from increasing patient demand. Unfortunately, a cure is not always possible particularly in this era of chronic complications, and the role of physicians has become limited to controlling and palliating symptoms.The increasing population of patients with longterm conditions are associated with high levels of morbidity, healthcare costs and GP workloads. Clinical pharmacy took over an aspect of medical care that had been partially abandoned by physicians. Overburdened by patient loads and the explosion of new drugs, physicians turned to pharmacists more and more for drug information, especially within institutional settings. Once relegated to counting and pouring, pharmacists headed institutional reviews of drug utilization and served as consultants to all types of health-care facilities. In addition, when clinical pharmacists are active members of the care team, they enhance proficiency by: Providing critical input on medicine use and dosing. Working with patients to solve problems with their medications and improve compliance.

show abstract

Breast Cancer Incidence Trends and Projections in Northeastern Thailand

Cited by 15 publications

References 15 publications

Body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies

Body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies

Trends in breast cancer incidence in Ho Chi Minh City 1996 - 2015: a registry-based study

Clinical Pharmacists in Chronic Care

Contact Info

Product

Resources

About